CVE-2015-3953

Summary

CVECVE-2015-3953
StatePUBLIC
Assigner[email protected]
Source PriorityCVE Program / NVD first with legacy fallback
Published2019-03-25 17:29:00 UTC
Updated2019-10-09 23:14:00 UTC
DescriptionHard-coded accounts may be used to access Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, version 3.13 and prior. Hospira recommends that customers close Port 20/FTP and Port 23/TELNET on the affected devices. Hospira has also released the Plum 360 Infusion System which is not vulnerable to this issue.

Risk And Classification

Problem Types: CWE-798

NVD Known Affected Configurations (CPE 2.3)

TypeVendorProductVersionUpdateEditionLanguage
Hardware Pifzer Plum A 3 Infusion System - All All All
Operating System Pifzer Plum A 3 Infusion System Firmware All All All All
Hardware Pifzer Plum A Infusion System - All All All
Operating System Pifzer Plum A Infusion System Firmware All All All All
Hardware Pifzer Plum A 3 Infusion System - All All All
Hardware Pifzer Plum A 3 Infusion System - All All All
Operating System Pifzer Plum A 3 Infusion System Firmware All All All All
Hardware Pifzer Plum A Infusion System - All All All
Hardware Pifzer Plum A Infusion System - All All All
Operating System Pifzer Plum A Infusion System Firmware All All All All
Hardware Pifzer Symbiq Infusion System - All All All
Hardware Pifzer Symbiq Infusion System - All All All
Operating System Pifzer Symbiq Infusion System Firmware All All All All

References

ReferenceSourceLinkTags
Hospira Plum A+ and Symbiq Infusion Systems Vulnerabilities | ICS-CERT MISC ics-cert.us-cert.gov Mitigation, Third Party Advisory, US Government Resource
CVE Program record CVE.ORG www.cve.org canonical
NVD vulnerability detail NVD nvd.nist.gov canonical, analysis

© CVE.report 2026

Use of this information constitutes acceptance for use in an AS IS condition. There are NO warranties, implied or otherwise, with regard to this information or its use. Any use of this information is at the user's risk. It is the responsibility of user to evaluate the accuracy, completeness or usefulness of any information, opinion, advice or other content. EACH USER WILL BE SOLELY RESPONSIBLE FOR ANY consequences of his or her direct or indirect use of this web site. ALL WARRANTIES OF ANY KIND ARE EXPRESSLY DISCLAIMED. This site will NOT BE LIABLE FOR ANY DIRECT, INDIRECT or any other kind of loss.

CVE, CWE, and OVAL are registred trademarks of The MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. This site includes MITRE data granted under the following license.

Free CVE JSON API cve.report/api

CVE.report and Source URL Uptime Status status.cve.report